CrossCare Intelligence Layer™
CrossCare Medical Access Intelligence™
Treatment is only real if you can get there in time.
Medical Access Intelligence combines clinical suitability with real-world entry feasibility, so a pathway is only recommended when the hospital can treat the condition and the patient can realistically arrive in time.
Optimised for time to treatment
Every recommendation is measured in days from records received to hospital arrival — not in brochure quality.
Entry feasibility, not guesswork
Invitation letters, biometrics, consular presence and companion policy are scored per origin country.
Parallel destination pathways
Urgent cases run two pathways at once, so no patient depends on a single consular decision.
Destination access at a glance
Planning guidance verified by the CrossCare consular desk. Typical decision times vary by origin country and mission workload.
| Destination | Entry route | Typical decision | Invitation | Verified |
|---|---|---|---|---|
| China | Medical (M / S2 category, depending on purpose) | 5–12 days | Hospital invitation required | 2026-02-01 |
| United Arab Emirates | Medical treatment entry permit (hospital or sponsor issued) | 2–6 days | Hospital invitation required | 2026-02-04 |
| Turkey | Medical visa (e-Visa available for some nationalities; sticker visa otherwise) | 4–12 days | Hospital invitation required | 2026-02-03 |
| India | Medical visa (MED) with medical attendant visas for companions | 4–14 days | Hospital invitation required | 2026-01-29 |
| Thailand | Medical treatment visa (Non-Immigrant MT) or visa on arrival for some nationalities | 3–10 days | Hospital invitation required | 2026-01-26 |
| South Korea | Medical tourism visa (C-3-3 / G-1-10 for longer treatment) | 7–18 days | Hospital invitation required | 2026-01-19 |
| Singapore | Short-term visit pass for medical treatment (with local sponsorship where required) | 5–14 days | Hospital invitation required | 2026-01-21 |
| Germany | Schengen medical visa (Type C) or national visa for extended treatment | 14–45 days | Hospital invitation required | 2026-01-14 |
| United Kingdom | Standard visitor visa (medical treatment) | 15–42 days | Hospital invitation required | 2026-01-14 |
| South Africa | Medical treatment visa (visa-exempt entry for several African nationalities) | 3–20 days | Hospital invitation required | 2026-01-23 |
| Japan | Medical stay visa with a registered guarantor organisation | 10–25 days | Hospital invitation required | 2026-01-16 |
Urgent escalation protocol
- 1Clinical urgency is certified in writing by a treating physician — CrossCare never certifies urgency itself.
- 2Hospital acceptance is requested with a documented response deadline.
- 3The invitation letter is requested as an urgent case through the hospital's international office.
- 4Where a mission offers it, an expedited or priority consular route is prepared with full documentation ready.
- 5A parallel destination pathway is opened so the patient is never dependent on a single decision.
- 6The coordinator reviews the case daily until the patient has travelled.
Medical Mobility Dossier™
Every case receives a unique Mobility ID and a single dossier that hospitals, missions and coordinators all work from.
- • Patient identity and passport summary
- • Certified clinical summary and treating physician details
- • Hospital acceptance and invitation letter
- • Treatment plan and cost estimate
- • Funding or sponsorship evidence
- • Travel plan, companions and escort requirements
- • Accommodation and recovery arrangements
- • Return and follow-up plan
Hospital Visa Capability Index™
How quickly participating hospitals respond, issue invitation letters and support consular verification. Ratings reflect operational performance only — never commercial arrangements.
Loading capability index…
Origin coverage
Consular conditions are modelled per origin country, starting with Africa.
Access estimates are planning guidance only. CrossCare does not issue visas, guarantee entry, or make clinical or immigration decisions. Visa outcomes rest with the relevant authorities and treatment decisions rest with licensed clinicians.
CrossCare does not diagnose or recommend treatment. Destination suitability reflects published hospital capability and coordination history, never commercial relationships.